Added therapeutic value of new drugs approved in Brazil from 2004 to 2016

Abstract: This study aimed to assess the level of therapeutic innovation of new drugs approved in Brazil over 13 years and whether they met public health needs. Comparative descriptive analysis of therapeutic value assessments performed by the Brazilian Chamber of Drug Market Regulation (CMED) and t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Rogério Hoefler (Autor), Teresa Leonardo Alves (Autor), Hubertus G. Leufkens (Autor), Janeth de Oliveira Silva Naves (Autor)
Format: Knjiga
Izdano: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2019-05-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno